Doses of Evusheld — a monoclonal antibody treatment provided via injection to people with COVID-19 — have made their way to the state.
"Statewide, our cases and hospitalizations are moving in the right direction, but there are still deaths from COVID-19 every day, and a rise in cases caused by new variants is always a possibility,” said Dr. Tao Sheng Kwan-Gett, state Chief Science Officer. "We want to make sure patients who are immunocompromised know about treatments like Evusheld. It could be a game-changer for those who need extra protection."
The state recommends that people with a high risk for severe disease from COVID-19 who are not eligible for Evusheld should ask their health care provider about other antiviral and monoclonal antibody treatments.
Evusheld was first released for use in December 2021 and was initially very difficult to access due to limited supply. Additional information on Evusheld for patients, parents and caregivers can be found here.